Naltrexone Accord (Naltrexone Hydrochloride)

Naltrexone Hydrochloride, the active ingredient in Naltrexone Accord, is an opioid antagonist presented as an oral dosage form for oral use. It is employed in the management of alcohol dependence and for relapse prevention in opioid dependence. GNH USA supplies Naltrexone Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naltrexone Accord acts on opioid receptors to modify dependence‑related pathways. - Alcohol dependence: reduces cravings and supports abstinence in individuals with alcohol use disorder. - Opioid dependence (relapse prevention): blocks reinforcing effects of opioids, helping maintain sobriety after detoxification. - Opioid use disorder: diminishes the risk of relapse by antagonising mu‑opioid receptors.

Naltrexone Accord may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Fatigue: feeling unusually tired.

Serious or Rare Side Effects: - Hepatotoxicity: signs of liver injury such as jaundice. - Severe depression or suicidal thoughts: emergent mood changes. - Allergic reactions: rash, swelling, or anaphylaxis.

Before initiating therapy, consider the following safety measures. - Liver function assessment: evaluate hepatic enzymes due to potential hepatotoxicity. - Psychiatric monitoring: watch for worsening depression or suicidal ideation. - Concomitant opioid use: avoid abrupt discontinuation of opioids to prevent withdrawal. - Renal impairment: adjust use in patients with reduced kidney function. - Pregnancy and lactation: discuss risks with a healthcare professional. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Naltrexone may interact with several medications, requiring careful management.

Major Interactions (Avoid): - Opioid agonists: can precipitate acute withdrawal. - Alcohol: may increase hepatotoxic risk. - Hepatotoxic drugs (e.g., isoniazid): additive liver injury.

Moderate Interactions (Monitor Closely): - Antidepressants: monitor mood changes. - Benzodiazepines: enhanced sedation risk. - Rifampin: may reduce naltrexone plasma levels.